Bionano Genomics Inc (BNGO)

3.600
+0.220(+6.51%)
After Hours
3.480
-0.120(-3.333%)
- Real-time Data
  • Volume:
    21,023,846
  • Day's Range:
    3.360 - 3.700
  • 52 wk Range:
    1.160 - 6.279
Unusual trading volume

BNGO Overview

Prev. Close
3.38
Day's Range
3.36-3.7
Revenue
20.52M
Open
3.45
52 wk Range
1.16-6.279
EPS
-0.373
Volume
21,023,846
Market Cap
1.04B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
7,777,504
P/E Ratio
-6.06
Beta
2.28
1-Year Change
-36.73%
Shares Outstanding
290,139,940
Next Earnings Date
Nov 10, 2022
What is your sentiment on Bionano Genomics?
or
Market is currently closed. Voting is open during market hours.

Bionano Genomics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Bionano Genomics Inc Analysis

Bionano Genomics Inc Company Profile

Bionano Genomics Inc Company Profile

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellBuyStrong BuyStrong BuyBuy
Technical IndicatorsNeutralStrong BuyStrong BuyStrong BuySell
SummaryNeutralStrong BuyStrong BuyStrong BuyNeutral
  • Genomics is going to be a trillion dollar industry. This will be $40+ one day.
    0
    • Keep it for 8-15 years aaa hahah we'll shirt it all the way up
      0
  • gold gains! Got out at 4.15. awaiting signal to enter
    0
    • Well my own experience, dont buy when spike occurs.. Await the fall and look for the support. Try not to fall for the FOMO 😀Im not sure atm where we heading, Logical would be downwards after this spike..
      0
    • Cool I'll wait for further downfall
      0
    • Keep us updated bro :D
      0
  • My precious
    0
    • Letsss goooooooo
      0
      • bingo
        0
        • Be alert if we pass 2.670 possible to fall to set new support ..
          1
          • Around what price is it best to buy in at?
            0
          • This is just my own prediction, I say await tomorrow for CPI and see how the market reacts. I think its possible this stock will try to go to 3$ level .. Not a finanical advice.
            0
          • Not a financial advice aaa haha cool I'll wait
            0
        • Well I was correct about earnings, Expanses and costs has increased due to the lack of chips. I can see that they are working hard to get their product out! Patience is needed here.. Earnings was not bad, but its not super good either.. I still think 2023 will be the year
          0
          • Nice. Any other stock I should have a look at?
            0
          • always such bad mojo for givin someone ticker advices. But take a look at CTRM, problary earnings soon and easy money to sell when report gets out, keep in mind that you gotta check their webpage severaltimes everyday. CTRM got alot of haterz on the management (Petroz). Its a bulktransport company ..Another one is GEVO but they got earnings today so wait for a big dipp befor entry.
            0
          • Thanks :)
            0
        • When its the earnings time?
          0
          • Bngo reported after market close as they said and earnings are mostly reported after market close
            0
        • Pump is done...now?
          0
          • If earnings are bad then it shall fall back again but if earnings are good then further upside movement is expected :)
            0
          • Its possible to reach 2.7-3$ but then prolly a fallback..
            0
        • Future is looking bright for Bionano.
          0
          • This is the Tesla of Genomics :D
            0